Cumberland Pharma CEO Kazimi Files SC 13G, Maintains Significant Stake

TL;DR

**Cumberland Pharma CEO A.J. Kazimi still owns a big chunk of the company, signaling insider confidence.**

AI Summary

A.J. Kazimi, the CEO of Cumberland Pharmaceuticals Inc., filed an Amendment No. 11 to Schedule 13G on February 9, 2024, indicating his beneficial ownership of the company's common stock as of December 31, 2023. This filing, under Rule 13d-1(d), is a routine disclosure for insiders and shows his continued significant stake. This matters to investors because a CEO's substantial ownership often signals confidence in the company's future, aligning his interests directly with those of shareholders.

Why It Matters

This filing confirms that CEO A.J. Kazimi continues to hold a significant beneficial ownership in Cumberland Pharmaceuticals, which can be a positive signal for investors as it aligns his personal financial success with the company's performance.

Risk Assessment

Risk Level: low — This is a routine disclosure filing by an insider, indicating no immediate new risks or changes in company fundamentals.

Analyst Insight

An investor should note that the CEO's continued beneficial ownership is a standard disclosure and generally a positive sign of alignment, but this filing alone doesn't provide new information for immediate trading decisions. Further research into the company's financials and strategic initiatives would be prudent.

Key Players & Entities

• A.J. Kazimi (person) — Reporting Person, CEO of Cumberland Pharmaceuticals Inc.
• Cumberland Pharmaceuticals Inc. (company) — Subject Company (Issuer)
• 03 Life Sciences (company) — Organization Name associated with the filing, though the reporting person is A.J. Kazimi
• December 31, 2023 (date) — Date of Event Which Requires Filing of this Statement
• February 9, 2024 (date) — Filing date of the SC 13G Amendment No. 11

FAQ

Filing Documents

• schedule13g-2023.htm (SC 13G) — 72KB
• 0001628280-24-004125.txt ( ) — 73KB

If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a

Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a Not applicable

Ownership

Item 4. Ownership. (a) Amount beneficially owned 5,721,267 (b) Percent of class 40.14% Page 3 of 5 pages (c) Number of shares as to which the person has (i) Sole power to vote or to direct the vote 5,721,267 (ii) Shared power to vote or to direct the vote None. (iii) Sole power to dispose or to direct the disposition of 5,721,267 (iv) Shared power to dispose or to direct the disposition of None.

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class Not applicable

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not applicable

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group Not applicable

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group Not applicable

Certification

Item 10. Certification Not applicable Page 4 of 5 pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 9, 2024 Date s A.J. Kazimi* Signature A.J. Kazimi, Chief Executive Officer NameTitle * By s John Hamm, as attorney-in-fact, pursuant to a Power of Attorney dated June 10, 2021 and filed with the SEC on June 11, 2021. Page 5 of 5 pages

View Full Filing

View this SC 13G filing on SEC EDGAR